_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019-preview-1.jpg "FDA Perspectives on Biosimilar BLA-Manufacturing (28of33) Quality – Oct. 16-17, 2019 from dbnpa fda Video Screenshot Preview 1")
Gallery_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019-preview-3.jpg "FDA Perspectives on Biosimilar BLA-Manufacturing (28of33) Quality – Oct. 16-17, 2019 from dbnpa fda Video Screenshot Preview 3")
Gallery_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019-preview-hqdefault.jpg "FDA Perspectives on Biosimilar BLA-Manufacturing (28of33) Quality – Oct. 16-17, 2019 from dbnpa fda Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 24 minutes 48 seconds
👁 View: 998 times
Play Audio:👁 View: 998 times
Description:
U.S. Food and Drug Administration
U.S. Food and Drug Administration
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_what-the-fda39s-approval-of-aducanumab-might-mean-for-a-booming-clinical-research-industry.webp "Dan Sfera")
⏲ 7 minutes 15 seconds 👁 95
_fda-nanoday-symposium-2022-welcome-keynote-and-session-1.webp "U.S. Food and Drug Administration")
_awani-tonight-synthetic-nicotine-in-vapes-may-be-more-potent-than-nicotine-fda-finds.webp "Nicotine alternatives in vapes may be more potent and addictive than nicotine itself, according to research by the US Food and Drug Administration and independent researchers.")
_about-fdas-biomarker-qualification-program.webp "U.S. Food and Drug Administration")
_fda-pulls-infant-formula-from-shelves-due-to-lack-of-evaluation.webp "Crecelac and Farmalac-branded infant formula is being recalled after being placed on shelves without proper evaluation by the Food and Drug Administration. According to the FDA, the products \")
_petrie-flom-center-124-assessing-the-viability-of-fdas-biosimilar-pathway.webp "Harvard Law School")
⏲ 1 hour 24 minutes 3 seconds 👁 150
_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019.webp "U.S. Food and Drug Administration")
⏲ 24 minutes 48 seconds 👁 998
_origins-of-dantrium-iv-part-12-fda-approval.webp "MHAUSvideo")
Related Video Searches
Back to Search
Search Videos
Recent Searches
×
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
_what-the-fda39s-approval-of-aducanumab-might-mean-for-a-booming-clinical-research-industry.jpg)
_fda-nanoday-symposium-2022-welcome-keynote-and-session-1.jpg)
_awani-tonight-synthetic-nicotine-in-vapes-may-be-more-potent-than-nicotine-fda-finds.jpg)
_about-fdas-biomarker-qualification-program.jpg)
_fda-pulls-infant-formula-from-shelves-due-to-lack-of-evaluation.jpg)
_petrie-flom-center-124-assessing-the-viability-of-fdas-biosimilar-pathway.jpg)
_fda-perspectives-on-biosimilar-bla-manufacturing-28of33-quality-oct-16-17-2019.jpg)
_origins-of-dantrium-iv-part-12-fda-approval.jpg)
❮❯
1 / 12
2 / 12
3 / 12
4 / 12
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
5 / 12
6 / 12
7 / 12
8 / 12
9 / 12
10 / 12
11 / 12
12 / 12
View Full Screen: fda perspectives on biosimilar bla manufacturing 28of33 quality oct 16 17 2019.mp4
![[+]](/images/menu.gif){kind=small}